Alivus Life Sciences Limited has informed the Exchange regarding Allotment of 92096 Shares.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has allotted 92,096 equity shares of face value Rs. 2 each to eligible employees who exercised their stock options under the 'Glenmark Life Sciences Limited - Employee Stock Option Scheme, 2021'. The allotment was approved by the Nomination and Remuneration Committee on April 30, 2025. Following this, the company's paid-up share capital has increased from Rs. 24,50,74,104 to Rs. 24,52,58,296, with total equity shares rising from 12,25,37,052 to 12,26,29,148. This is a routine ESOP-related allotment with a very minor dilution of approximately 0.075% in total share count.
Minimal impact on shareholders; this is a routine ESOP allotment resulting in negligible dilution (~0.075%). Shareholders should note a very slight increase in total shares outstanding but no material change to company value or shareholding structure.